FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| METHOTREXATE SODIUM | 59137-530-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-535-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-535-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-535-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-540-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-540-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-540-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-550-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-550-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59137-550-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 59651-182-01 | Aurobindo Pharma Limited | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 59651-182-36 | Aurobindo Pharma Limited | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 61703-124-40 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-09 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-10 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-37 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-350-38 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-408-25 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 61703-408-41 | Hospira, Inc. | NDA011719 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 62135-772-35 | Chartwell RX, LLC | ANDA210454 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 63323-122-50 | Fresenius Kabi USA, LLC | ANDA040266 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 63323-123-10 | Fresenius Kabi USA, LLC | ANDA040263 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE SODIUM | 66336-338-21 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE SODIUM | 66336-338-30 | Dispensing Solutions, Inc. | NDA008085 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 68382-775-01 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-05 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-10 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-16 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-60 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-77 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-
